Ipsen S.A. (IPSEY) Comparison with companies in other sectors?

Ipsen S.A. has a share price of 1.32B. You can analyze Ipsen S.A. (IPSEY) competitors across different market sectors through stock heatmaps.

What are IPSEY's NET and operating margins?

Ipsen S.A. (IPSEY) operating margin is around 0.24, and net profit margin is approximately 0.20 as of the latest reports.

In what way does IPSEY's earnings per share (EPS) trend reflect its financial momentum?

Ipsen S.A. (IPSEY) EPS is 1.24 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Ipsen S.A. is 26.15, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Ipsen S.A.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Ipsen S.A. like P/E which is 53.58, P/B which is 9.02, and PEG which is 8.77. Compare them with sector averages to evaluate if the stock is priced fairly.

Ipsen S.A.

IPSEY•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$32.42

$-0.58(-1.76%)

Fundamental Analysis of Ipsen S.A. (IPSEY)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$1.24

P/E Ratio

26.15

ROE

0.17%

Net Margin

0.20%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$42.91B

Shares OutstandingTotal number of shares issued

$1.32B

Book Value/ShareNet worth per share

$12.24

Revenue/ShareAnnual revenue per share

$10.11

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$1.24

Net MarginNet income as percentage of revenue

20.38%

Operating MarginOperating income as percentage of revenue

23.59%

ROEReturn on shareholders' equity

17.31%

ROAReturn on total assets

10.40%

ROCEReturn on capital employed

16.15%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$2.19

Cash/ShareCash and equivalents per share

$1.47

FCF YieldFree cash flow as percentage of market cap

1.99%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.22

Dividend YieldAnnual dividend as percentage of stock price

0.80%

Financial Ratios Analysis data is not available for IPSEYFinancial Ratios Analysis details for IPSEY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for IPSEYSector Benchmarking details for IPSEY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Ipsen S.A. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Ipsen S.A.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Ipsen S.A.'s unique business strengths and challenges.

Key Financial Metrics for Ipsen S.A.

For Ipsen S.A., essential financial indicators include EPS 1.24, PE 26.15, and ROE 0.17. These key ratios reveal insights into Ipsen S.A.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Ipsen S.A. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Ipsen S.A.

Metrics like Net Margin 20.38% and ROA 10.40% shed light on how well Ipsen S.A. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Ipsen S.A. can sustain its operations and continue growing in the future.

Valuation and Market Position of Ipsen S.A.

Using ratios such as P/B Ratio 9.02 and PEG Ratio 8.77, investors can assess whether Ipsen S.A. is appropriately valued based on its financials and growth potential. These figures, combined with Ipsen S.A.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Ipsen S.A.

Financial health indicators, such as Debt/Equity Ratio 0.12 and Cash Flow $2.19, provide a snapshot of Ipsen S.A.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Ipsen S.A., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Ipsen S.A.

Investing in Ipsen S.A. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Ipsen S.A. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;